Skip to content
Find a Provider
Thomas Wychowski, M.D.

Thomas Wychowski, M.D.

Neurology, Medicine

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 341-7500
Fax (585) 756-2311
Administrative (585) 275-9403

Locations

Epilepsy Center

601 Elmwood Avenue, Box 673
Rochester, NY 14642

(585) 275-1200 Get Directions
Epilepsy Center

2400 South Clinton Avenue
Rochester, NY 14618

(585) 275-1200 Get Directions

About Me

Professional Background

Thomas Wychowski is an Assistant Professor of Neurology at the University of Rochester. He has clinical interests in epilepsy and clinical neurophysiology. His research interests include diagnosis and treatment of epilepsy in patients with brain tumors.

Dr. Wychowski earned his BS in neuros...
Thomas Wychowski is an Assistant Professor of Neurology at the University of Rochester. He has clinical interests in epilepsy and clinical neurophysiology. His research interests include diagnosis and treatment of epilepsy in patients with brain tumors.

Dr. Wychowski earned his BS in neuroscience from the University of Rochester. He received his doctorate of medicine from the School of Medicine at SUNY Buffalo prior to returning to the Strong Memorial Hospital where he completed his Neurology Residency. He completed fellowship training in clinical neurophysiology and epilepsy at the University of Rochester.

He is an active member of the American Academy of Neurology, the American Epilepsy Society and the New York State Neurological Society.

Faculty Appointments

Associate Professor - Department of Neurology, Epilepsy (SMD)

Credentials

Residency & Fellowship

Fellowship, Epilepsy, University of Rochester Medical Center. 2012 - 2013

Fellowship, Clinical Neurophysiology, University of Rochester Medical Center. 2011 - 2012

Residency, Neurology, University of Rochester Medical Center. 2008 - 2011

Internship, Internal Medicine, University of Rochester Medical Center. 2007 - 2008

Education

MD | SUNY at Buffalo-School of Medicine & Biomedical Sciences (USA). 2007

Awards

Neurology Fellow Teaching Award. 2012

AAN Annual Meeting Resident Scholarship. 2011

AAN Medical Student Prize for Excellence. 2007

de Kiewiet Fellow. 2002

Rush Rhees Scholar. 1999 - 2003

Daimler Chrysler Corporation Scholarship. 1999 - 2003

Wegmans Employee Scholarship. 1999 - 2003

Polish National Alliance Scholar. 1999 - 2003

Research

Dr. Wychowski's research interests include diagnosis and treatment of epilepsy in patients with brain tumors.

Clinical Trials

Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas

Lead Researcher: Thomas Wychowski

The purpose of this study is to determine whether the study medication, brivaracetam, is tolerable and safe for patients with brain tumors.

A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS, TOLERABILITY, AND SAFETY OF A SINGLE DOSE OF STACCATO ALPRAZOLAM IN ADOLESCENT STUDY PARTICIPANTS WITH EPILEPSY

Lead Researcher: Thomas Wychowski

After a screening visit, subjects between the age of 12-17 would be admitted to the Clinical Research Center for 36 hours. During their admission, they would receive a single dose of alprazolam by inhaling the medication into their lungs. They would ...

Publications

Journal Articles

Improved ictal assessment performance in the epilepsy monitoring unit via standardization.

Hanrahan B, Gross RA, Wychowski T, Erba G, Birbeck GL, Liu L

Epilepsy & behavior : E&B.. 2021 June 16122 :108067. Epub 06/16/2021.

Isocitrate dehydrogenase mutations: A biomarker for glioma-related excitability and seizures.

Wychowski T, Kapur J

Neurology.. 2017 May 988 (19):1782-1783. Epub 04/12/2017.

Qualitative analysis of double inversion recovery MRI in drug-resistant epilepsy.

Wychowski T, Hussain A, Tivarus ME, Birbeck GL, Berg MJ, Potchen M

Epilepsy research.. 2016 November 127 :195-199. Epub 09/03/2016.

Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs.

Wychowski T, Wang H, Buniak L, Henry JC, Mohile N

Clinical neurology and neurosurgery.. 2013 November 115 (11):2365-9. Epub 09/01/2013.